Clinical Trials Directory

Trials / Sponsors / Aeglea Biotherapeutics

Aeglea Biotherapeutics

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Study of Safety of Weekly Subcutaneous Pegzilarginase in Subjects With Arginase 1 Deficiency
Arginase I Deficiency, Hyperargininemia
Phase 32023-04-04
TerminatedA Multiple Ascending Dose Study of ACN00177 (Pegtarviliase) in Subjects With CBS Deficiency
Homocystinuria Due to Cystathionine Beta-Synthase Deficiency
Phase 1 / Phase 22021-05-13
CompletedEfficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency
Arginase I Deficiency, Hyperargininemia
Phase 32019-04-10
CompletedPegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer
Small-cell Lung Cancer
Phase 1 / Phase 22017-12-21
CompletedA Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency
Arginase I Deficiency, Hyperargininemia
Phase 22017-12-07
CompletedA Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS
Acute Myeloid Leukemia, Myelodysplastic Syndrome
Phase 22016-08-01
CompletedA Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency
Arginase I Deficiency, Hyperargininemia
Phase 1 / Phase 22016-06-01
CompletedA Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors
Advanced Cancers
Phase 1 / Phase 22015-10-01